drugset / Trial / NCT00307567

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Phase 2 Completed 689 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelPrevention

Summary

Booster and immune memory study

Timeline

Start
2005-11
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pneumovax 23 Vaccine
Subject Synflorix Vaccine